Bacteroides thetaiotaomicron CAG:40

Information

Microbe Identification

Bacteroides thetaiotaomicron CAG:40

Microbe id: PMDBM2021776
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Bacteroides thetaiotaomicron CAG:40 [1263054]
Taxonomy Genus: Bacteroides [816]
Taxonomy Family: Bacteroidaceae [815]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Bacteroides thetaiotaomicron CAG:40

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Bacteroides thetaiotaomicron CAG:40


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Bacteroides thetaiotaomicron CAG:40 distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Bacteroides thetaiotaomicron CAG:40 in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Bacteroides thetaiotaomicron CAG:40

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗4.59625899709271mNGS
Hemangioma, Cavernous PRJNA629755🔗5.15907075082902mNGS
Hypertension PRJNA509999🔗5.32358224437918mNGS
Diabetes Mellitus, Type 2 PRJDB5860🔗4.4540548608401516S
Diarrhea PRJNA317326🔗-4.7048019938995916S
Colorectal Neoplasms PRJNA464414🔗-5.3118322168144316S
Colorectal Neoplasms PRJNA1126038🔗-4.8219755559306716S
Colorectal Neoplasms PRJNA961076🔗-4.5477669807291mNGS
Colorectal Neoplasms PRJEB53415🔗-4.3993648093444416S
Colorectal Neoplasms PRJEB46665🔗-3.6491112736408816S
Colorectal Neoplasms PRJNA763023🔗4.81542870066452mNGS
Colorectal Neoplasms PRJNA888860🔗4.86573027390304mNGS
Colorectal Neoplasms PRJNA731589🔗4.91772837662016mNGS
Colorectal Neoplasms PRJNA824020🔗4.9621188442756416S
Tuberculosis, Gastrointestinal PRJNA743795🔗-5.0565353447933616S
Lupus Erythematosus, Systemic PRJEB52971🔗4.687774591225516S
Diabetes Mellitus, Type 1 PRJNA604850🔗4.64866825743164mNGS
Mental Disorders PRJNA278793🔗-5.3336860970915416S
Hepatitis, Autoimmune PRJNA556801🔗-4.9120923714550316S
Parkinson Disease PRJNA626004🔗-4.83724047540482mNGS
Parkinson Disease PRJEB59350🔗4.38958479298383mNGS
Colitis, Ulcerative PRJNA917086🔗-4.7777881127624416S
Colitis, Ulcerative PRJNA820056🔗4.0199896502712416S
Colitis, Ulcerative PRJNA398089🔗4.72319376362628mNGS
Spinal Cord Injuries PRJNA861246🔗5.2416553641557216S
Hepatitis B, Chronic PRJNA872871🔗-5.0655610414935616S
Osteoporosis, Postmenopausal PRJNA631117🔗5.3371099096411616S
Macular Degeneration PRJNA799475🔗4.3326817017094616S
Hepatolenticular Degeneration PRJNA1038771🔗-5.0533808154446716S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-5.377431768191216S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗4.7394509279979916S
Asthma PRJNA950484🔗5.0174014727410716S
Crohn Disease PRJNA820056🔗3.967561048987616S
Crohn Disease PRJNA398089🔗4.82429926405235mNGS
Crohn Disease PRJNA793776🔗5.00260499674094mNGS
Crohn Disease PRJEB76677🔗5.09051878141366mNGS
Crohn Disease PRJNA429990🔗5.14516834647261mNGS
Psoriasis PRJNA574485🔗-4.0501650497548216S
Psoriasis PRJNA938297🔗-4.01063550579395mNGS
Polycystic Ovary Syndrome PRJNA530971🔗4.84147567724199mNGS
Polycystic Ovary Syndrome PRJEB38647🔗4.9827896717943816S
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗-5.0068510184069116S
Diabetic Retinopathy PRJNA857030🔗5.054591346332216S
Arthritis, Rheumatoid PRJNA896336🔗-4.92778400893493mNGS
Arthritis, Rheumatoid PRJNA786110🔗-4.6452341277204616S
Arthritis, Rheumatoid PRJNA753264🔗4.5330760922125416S
Arthritis, Rheumatoid PRJNA356102🔗4.74314721055068mNGS
Arthritis, Rheumatoid PRJNA574565🔗4.9116015226617516S
Fatigue Syndrome, Chronic PRJNA379741🔗4.81206412278308mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗4.84530500973257mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗4.91433072668389mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗3.75179050837116S
Cholangiocarcinoma PRJNA932948🔗-4.71223988752193mNGS
Growth Hormone-Secreting Pituitary Adenoma PRJNA743650🔗3.6847106095853116S
Neuroblastoma PRJNA716780🔗-4.47959150670511mNGS
Neuroblastoma PRJEB63351🔗-4.13755714185737mNGS
Digestive System Diseases PRJNA438404🔗4.5975741992436116S
Irritable Bowel Syndrome PRJNA682378🔗-4.6616632615386116S
Irritable Bowel Syndrome PRJEB37924🔗4.0732461732679mNGS
Irritable Bowel Syndrome PRJNA637763🔗4.6597837788834816S
Gastroesophageal Reflux PRJNA993632🔗4.94748151766125mNGS
Clostridium Infections PRJNA648321🔗-5.22929809605492mNGS
Pancreatic Neoplasms PRJNA665854🔗5.01457338789623mNGS
Cholelithiasis PRJNA999028🔗5.05383621526286mNGS
Alzheimer Disease PRJEB51982🔗4.8874362466660316S
Lung Neoplasms PRJNA507734🔗4.5122192118504916S
Glomerulonephritis, IGA PRJNA785415🔗-4.9547066297031716S
Liver Cirrhosis PRJNA861246🔗5.2831480515246316S
Cystic Fibrosis PRJNA314903🔗-4.95395318692604mNGS
Obesity PRJNA794317🔗-3.9478537718800916S
Diabetes Mellitus PRJNA774037🔗4.4652887261176616S
Enterocolitis, Necrotizing PRJNA889687🔗-4.7644631299988416S
HIV Infections PRJDB11949🔗-4.5784084854319216S
HIV Infections PRJNA995875🔗-3.8804779913727516S
Neuromyelitis Optica PRJNA662563🔗5.1984094421001816S
Inflammatory Bowel Diseases PRJNA993675🔗-4.74565122025215mNGS
Inflammatory Bowel Diseases PRJNA511372🔗4.22594463951777mNGS
Renal Insufficiency, Chronic PRJNA949558🔗-5.1729826165504816S
Renal Insufficiency, Chronic PRJNA659589🔗-4.6256035000761216S
Renal Insufficiency, Chronic PRJNA562327🔗4.4753710831585416S
Multiple Sclerosis PRJNA721421🔗4.8195516974258516S
Multiple Sclerosis PRJEB34168🔗5.0448332978505416S
Breast Neoplasms PRJNA658160🔗5.236547172104216S
COVID-19 PRJNA769052🔗-5.2085158981767916S
COVID-19 PRJNA689961🔗4.7490931616224mNGS
COVID-19 PRJNA624223🔗5.04744179055401mNGS
COVID-19 PRJNA767939🔗5.2133299679169816S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Bacteroides thetaiotaomicron CAG:40



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Bacteroides thetaiotaomicron CAG:40



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Bacteroides thetaiotaomicron CAG:40

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Bacteroides thetaiotaomicron CAG:40


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Bacteroides thetaiotaomicron CAG:40



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Bacteroides thetaiotaomicron CAG:40

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Bacteroides thetaiotaomicron CAG:40

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Bacteroides thetaiotaomicron CAG:40

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Bacteroides thetaiotaomicron CAG:40



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Bacteroides thetaiotaomicron CAG:40


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Bacteroides thetaiotaomicron CAG:40


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?